Literature DB >> 21196588

Combination therapy of abatacept and anakinra in children with refractory systemic juvenile idiopathic arthritis: a retrospective case series.

Jessica L Record, Timothy Beukelman, Randy Q Cron.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21196588     DOI： 10.3899/jrheum.100726

Source DB:  PubMed          Journal:  J Rheumatol        ISSN： 0315-162X            Impact factor:   4.666


× No keyword cloud information.
  25 in total

1.  [Recommendations for use of abatacept in patients with rheumatoid arthritis].

Authors:  M Gaubitz; K Krüger; J-P Haas
Journal:  Z Rheumatol       Date:  2014-12       Impact factor: 1.372

2.  Rationale and study design for a phase I/IIa trial of anakinra in children with Kawasaki disease and early coronary artery abnormalities (the ANAKID trial).

Authors:  Adriana H Tremoulet; Sonia Jain; Susan Kim; Jane Newburger; Moshe Arditi; Alessandra Franco; Brookie Best; Jane C Burns
Journal:  Contemp Clin Trials       Date:  2016-04-11       Impact factor: 2.226

Review 3.  From bench to bedside and back again: translational research in autoinflammation.

Authors:  Dirk Holzinger; Christoph Kessel; Alessia Omenetti; Marco Gattorno
Journal:  Nat Rev Rheumatol       Date:  2015-06-16       Impact factor: 20.543

Review 4.  2013 update of the 2011 American College of Rheumatology recommendations for the treatment of juvenile idiopathic arthritis: recommendations for the medical therapy of children with systemic juvenile idiopathic arthritis and tuberculosis screening among children receiving biologic medications.

Authors:  Sarah Ringold; Pamela F Weiss; Timothy Beukelman; Esi Morgan Dewitt; Norman T Ilowite; Yukiko Kimura; Ronald M Laxer; Daniel J Lovell; Peter A Nigrovic; Angela Byun Robinson; Richard K Vehe
Journal:  Arthritis Care Res (Hoboken)       Date:  2013-10       Impact factor: 4.794

5.  2013 update of the 2011 American College of Rheumatology recommendations for the treatment of juvenile idiopathic arthritis: recommendations for the medical therapy of children with systemic juvenile idiopathic arthritis and tuberculosis screening among children receiving biologic medications.

Authors:  Sarah Ringold; Pamela F Weiss; Timothy Beukelman; Esi Morgan DeWitt; Norman T Ilowite; Yukiko Kimura; Ronald M Laxer; Daniel J Lovell; Peter A Nigrovic; Angela Byun Robinson; Richard K Vehe
Journal:  Arthritis Rheum       Date:  2013-10

6.  A Heterozygous RAB27A Mutation Associated with Delayed Cytolytic Granule Polarization and Hemophagocytic Lymphohistiocytosis.

Authors:  Mingce Zhang; Claudia Bracaglia; Giusi Prencipe; Christina J Bemrich-Stolz; Timothy Beukelman; Reed A Dimmitt; W Winn Chatham; Kejian Zhang; Hao Li; Mark R Walter; Fabrizio De Benedetti; Alexei A Grom; Randy Q Cron
Journal:  J Immunol       Date:  2016-02-15       Impact factor: 5.422

7.  Th17 reprogramming of T cells in systemic juvenile idiopathic arthritis.

Authors:  Lauren A Henderson; Kacie J Hoyt; Pui Y Lee; Deepak A Rao; A Helena Jonsson; Jennifer P Nguyen; Kayleigh Rutherford; Amélie M Julé; Louis-Marie Charbonnier; Siobhan Case; Margaret H Chang; Ezra M Cohen; Fatma Dedeoglu; Robert C Fuhlbrigge; Olha Halyabar; Melissa M Hazen; Erin Janssen; Susan Kim; Jeffrey Lo; Mindy S Lo; Esra Meidan; Mary Beth F Son; Robert P Sundel; Matthew L Stoll; Chad Nusbaum; James A Lederer; Talal A Chatila; Peter A Nigrovic
Journal:  JCI Insight       Date:  2020-03-26

8.  Systemic arthritis in children: a review of clinical presentation and treatment.

Authors:  R Gurion; T J A Lehman; L N Moorthy
Journal:  Int J Inflam       Date:  2011-12-25

9.  HLA-DRB1*11 and variants of the MHC class II locus are strong risk factors for systemic juvenile idiopathic arthritis.

Authors:  Michael J Ombrello; Elaine F Remmers; Ioanna Tachmazidou; Alexei Grom; Dirk Foell; Johannes-Peter Haas; Alberto Martini; Marco Gattorno; Seza Özen; Sampath Prahalad; Andrew S Zeft; John F Bohnsack; Elizabeth D Mellins; Norman T Ilowite; Ricardo Russo; Claudio Len; Maria Odete E Hilario; Sheila Oliveira; Rae S M Yeung; Alan Rosenberg; Lucy R Wedderburn; Jordi Anton; Tobias Schwarz; Anne Hinks; Yelda Bilginer; Jane Park; Joanna Cobb; Colleen L Satorius; Buhm Han; Elizabeth Baskin; Sara Signa; Richard H Duerr; J P Achkar; M Ilyas Kamboh; Kenneth M Kaufman; Leah C Kottyan; Dalila Pinto; Stephen W Scherer; Marta E Alarcón-Riquelme; Elisa Docampo; Xavier Estivill; Ahmet Gül; Paul I W de Bakker; Soumya Raychaudhuri; Carl D Langefeld; Susan Thompson; Eleftheria Zeggini; Wendy Thomson; Daniel L Kastner; Patricia Woo
Journal:  Proc Natl Acad Sci U S A       Date:  2015-11-23       Impact factor: 11.205

10.  Intravenous administration of anakinra in children with macrophage activation syndrome.

Authors:  Omkar Phadke; Kelly Rouster-Stevens; Helen Giannopoulos; Shanmuganathan Chandrakasan; Sampath Prahalad
Journal:  Pediatr Rheumatol Online J       Date:  2021-06-29       Impact factor: 3.054
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.